Literature DB >> 17052168

Cellular functions of the BRCA tumour-suppressor proteins.

S J Boulton1.   

Abstract

Inherited germline mutations in either BRCA1 or BRCA2 confer a significant lifetime risk of developing breast or ovarian cancer. Defining how these two genes function at the cellular level is essential for understanding their role in tumour suppression. Although BRCA1 and BRCA2 were independently cloned over 10 years ago, it is only in the last few years that significant progress has been made towards understanding their function in cells. It is now widely accepted that both genes play critical roles in the maintenance of genome stability. Evidence implicates BRCA2 as an integral component of the homologous recombination machinery, whereas BRCA1 is an E3 ubiquitin ligase that has an impact on DNA repair, transcriptional regulation, cell-cycle progression and meiotic sex chromosome inactivation. In this article, I will review the most recent advances and provide a perspective of potential future directions in this field.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052168     DOI: 10.1042/BST0340633

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  63 in total

1.  Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.

Authors:  Arnaldo A Arbini; Margherita Greco; Jorge L Yao; Patricia Bourne; Ersilia Marra; Jer-Tsong Hsieh; Paul A di Sant'agnese; Loredana Moro
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  DNA repair: Decision at the break point.

Authors:  Simon J Boulton
Journal:  Nature       Date:  2010-05-20       Impact factor: 49.962

Review 3.  E3 ubiquitin ligases in ErbB receptor quantity control.

Authors:  Kermit L Carraway
Journal:  Semin Cell Dev Biol       Date:  2010-09-22       Impact factor: 7.727

Review 4.  Successful design and conduct of genome-wide association studies.

Authors:  Christopher I Amos
Journal:  Hum Mol Genet       Date:  2007-06-27       Impact factor: 6.150

5.  Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers.

Authors:  Anouk Pijpe; Peggy Manders; Renée L Mulder; Flora E van Leeuwen; Matti A Rookus
Journal:  Eur J Epidemiol       Date:  2010-02       Impact factor: 8.082

6.  DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells.

Authors:  Zhiyong Mao; Ying Jiang; Xiang Liu; Andrei Seluanov; Vera Gorbunova
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

7.  Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.

Authors:  Anna W Maniccia; Catherine Lewis; Nurjahan Begum; Jingyao Xu; Jianqi Cui; Galina Chipitsyna; Kartik Aysola; Vaishali Reddy; Ganapathy Bhat; Yasuo Fujimura; Beric Henderson; E Shyam P Reddy; Veena N Rao
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

8.  Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter.

Authors:  Jinhua Wang; Chunjing Bian; Jing Li; Fergus J Couch; Kangjian Wu; Robert Chunhua Zhao
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

9.  Toward classification of BRCA1 missense variants using a biophysical approach.

Authors:  Pamela J E Rowling; Rebecca Cook; Laura S Itzhaki
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

10.  BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells.

Authors:  Songmin Ying; Katie Myers; Sarah Bottomley; Thomas Helleday; Helen E Bryant
Journal:  Nucleic Acids Res       Date:  2009-06-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.